meloxicam
2 articles · search the full text for this term
-
Design And Evaluation Of Meloxicam Tablet For Colon Cancer
Abstract: Meloxicam, recognized as a preferential COX-2 inhibitor, has emerged as a promising chemopreventive agent for colorectal cancer. Leveraging its local and targeted action on the colon, Meloxicam proves to be a formidable component in the prevention of colorectal malignancies. This study aims to innovate by formulating and evaluating a targeted tablet delivery system for Meloxicam, emphasizing site-specific and instant drug release in the colon, thereby maximizing its therapeutic efficacy in …
Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 10, Issue 3, 2023 · pp. 1–7 Read article
-
Formulation Development of Meloxicam Loaded Transdermal Patches and Their Evaluation
Abstract: The current studies aim the Formulation and development of transdermal patches of Meloxicam. Meloxicam is a Non- Steroidal Anti-inflammatory Drug. Transdermal patches show better patient compliance over conventional dosage forms because of their longer time of operation resulting in a reduction in less frequent dosing. Six batches of transdermal patches were prepared using different concentrations of hydroxyl propyl methyl cellulose, ethyl cellulose, and polyvinyl pyrrolidone to increase the physical properties …
Published in Research & Reviews: A Journal of Drug Formulation, Development and Production · Vol. 8, Issue 1, 2023 · pp. 12–22 Read article